InMed Pharmaceuticals Inc. Company Profile
NASDAQ: INMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:45 AM ET
InMed Pharmaceuticals at a glance
InMed Pharmaceuticals Inc. (NASDAQ: INM) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Vancouver, BC, Canada. InMed Pharmaceuticals is led by Mr. Eric A. Adams B.S. Chem., M.I.B. and employs about 6 people. At a market capitalization of $7.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001728328, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does InMed Pharmaceuticals do?
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- InMed Pharmaceuticals Inc.
- Ticker
- NASDAQ: INM
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Eric A. Adams B.S. Chem., M.I.B.
- Employees
- 6
- Headquarters
- 500 West Georgia Street, Vancouver, BC, Canada
- Phone
- 604 669 7207
- Website
- inmedpharma.com
- Market cap
- $7.31M
- SEC CIK
- 0001728328
Companies similar to InMed Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| APUSApimeds Pharmaceuticals US Inc. | 4.87 | -11.77% | $7.34M | vs INM |
| APREAprea Therapeutics Inc. | 0.5846 | +4.73% | $7.36M | vs INM |
| NRSNNeuroSense Therapeutics Ltd. | 3.80 | +1.71% | $7.22M | vs INM |
| ACXPAcurx Pharmaceuticals Inc. | 1.27 | +1.60% | $7.06M | vs INM |
| BOLTBolt Biotherapeutics Inc. | 3.95 | +8.82% | $7.61M | vs INM |
| SKYESkye Bioscience Inc. | 1.74 | +3.27% | $7.68M | vs INM |
| LEXXLexaria Bioscience Corp. | 3.66 | +8.78% | $7.70M | vs INM |
| TRAWTraws Pharma Inc. | 0.4477 | -6.79% | $6.88M | vs INM |